comparemela.com

Latest Breaking News On - Lcs cae cadx software as medical device - Page 1 : comparemela.com

Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First

H1 2023 revenue at €11.4M, an increase from H2 2022 revenue (€11.1M).Order backlog at €64.6M as at June 30, 2023, +€2.6M compared to March 31, 2023, +€3.8M compared to December 31, 2022.Onboarding of academic sites involved in the pivotal validation plan in progress for the iBiopsy® LCS CADe/CADx software as medical.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.